Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages

New treatments and novel drugs are required to counter the growing problem of drug-resistant strains of Mycobacterium tuberculosis (M.tb). Our approach against drug resistant M.tb, as well as other intracellular pathogens, is by targeted drug delivery using nanoformulations of drugs already in use, as well as drugs in development. Among the latter are gallium (III) (Ga)-based compounds. In the current work, six different types of Ga and rifampin nanoparticles were prepared in such a way as to enhance targeting of M.tb infected-macrophages. They were then tested for their ability to inhibit growth of a fully pathogenic strain (H37Rv) or a non-pathogenic strain (H37Ra) of M.tb. Encapsulating Ga in folate- or mannose-conjugated block copolymers provided sustained Ga release for 15 days and significantly inhibited M.tb growth in human monocyte-derived macrophages. Nanoformulations with dendrimers encapsulating Ga or rifampin also showed promising anti-tuberculous activity. The nanoparticles co-localized with M.tb containing phagosomes, as measured by detection of mature cathepsin D (34 kDa, lysosomal hydrogenase). They also promoted maturation of the phagosome, which would be expected to increase macrophage-mediated killing of the organism. Delivery of Ga or rifampin in the form of nanoparticles to macrophages offers a promising approach for the development of new therapeutic anti-tuberculous drugs.

[1]  E. Chi,et al.  Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. , 1995, The American journal of pathology.

[2]  B. Britigan,et al.  Prolonged-acting, Multi-targeting Gallium Nanoparticles Potently Inhibit Growth of Both HIV and Mycobacteria in Co-Infected Human Macrophages , 2015, Scientific Reports.

[3]  H. Kalbacher,et al.  Cathepsin D: a cellular roadmap. , 2008, Biochemical and biophysical research communications.

[4]  Dina M M Alsadek,et al.  Galectin-3 as a Potential Target to Prevent Cancer Metastasis , 2015, Clinical Medicine Insights. Oncology.

[5]  B. Britigan,et al.  Gallium Disrupts Iron Metabolism of Mycobacteria Residing within Human Macrophages , 2000, Infection and Immunity.

[6]  S. Hinrichs,et al.  Discovery of bicyclic inhibitors against menaquinone biosynthesis. , 2016, Future medicinal chemistry.

[7]  Iron Acquisition from Pseudomonas aeruginosa Siderophores by Human Phagocytes: an Additional Mechanism of Host Defense through Iron Sequestration? , 2000, Infection and Immunity.

[8]  B. Britigan,et al.  Gallium Nitrate Is Efficacious in Murine Models of Tuberculosis and Inhibits Key Bacterial Fe-Dependent Enzymes , 2013, Antimicrobial Agents and Chemotherapy.

[9]  A. Erickson.  Biosynthesis of lysosomal endopeptidases , 1989, Journal of cellular biochemistry.

[10]  Francesco Stellacci,et al.  Effect of surface properties on nanoparticle-cell interactions. , 2010, Small.

[11]  B. Britigan,et al.  Ga(III) Nanoparticles Inhibit Growth of both Mycobacterium tuberculosis and HIV and Release of Interleukin-6 (IL-6) and IL-8 in Coinfected Macrophages , 2017, Antimicrobial Agents and Chemotherapy.

[12]  H. Gendelman,et al.  Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[13]  V. A. Kelley,et al.  Mycobacterium's arrest of phagosome maturation in macrophages requires Rab5 activity and accessibility to iron. , 2003, Molecular biology of the cell.

[14]  V. Deretic,et al.  Mycobacterial phagosome maturation, rab proteins, and intracellular trafficking , 1997, Electrophoresis.

[15]  P. De,et al.  The emergence of extensively drug-resistant tuberculosis (TB): TB/HIV coinfection, multidrug-resistant TB and the resulting public health threat from extensively drug-resistant TB, globally and in Canada. , 2007, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[16]  Seoung-ryoung Choi,et al.  Novel long-chain compounds with both immunomodulatory and MenA inhibitory activities against Staphylococcus aureus and its biofilm , 2017, Scientific Reports.

[17]  P. Draper,et al.  Mycobacteria and Lysosomes: a Paradox , 1969, Nature.

[18]  S. Kannan,et al.  Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications , 2014, Journal of internal medicine.

[19]  H. Drakesmith,et al.  Viral infection and iron metabolism , 2008, Nature Reviews Microbiology.

[20]  A. Dietz,et al.  Maturation of human monocyte-derived dendritic cells studied by microarray hybridization. , 2000, Biochemical and biophysical research communications.

[21]  H. Gendelman,et al.  NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery. , 2009, Nanomedicine.

[22]  J. Gaddy,et al.  Role of Acinetobactin-Mediated Iron Acquisition Functions in the Interaction of Acinetobacter baumannii Strain ATCC 19606T with Human Lung Epithelial Cells, Galleria mellonella Caterpillars, and Mice , 2012, Infection and Immunity.

[23]  H. Gendelman,et al.  Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. , 2006, Blood.

[24]  S. Hinrichs,et al.  Development of potential broad spectrum antimicrobials using C2-symmetric 9-fluorenone alkyl amine. , 2016, Bioorganic & medicinal chemistry letters.

[25]  A. Garofalo,et al.  Dendrimer-nanoparticle conjugates in nanomedicine. , 2015, Nanomedicine.

[26]  D. Crick,et al.  Chemoenzymatic synthesis of 4-diphosphocytidyl-2-C-methyl-D-erythritol: A substrate for IspE. , 2008, Tetrahedron letters.

[27]  B. Britigan,et al.  The Nature of Extracellular Iron Influences Iron Acquisition by Mycobacterium tuberculosis Residing within Human Macrophages , 2004, Infection and Immunity.

[28]  V. Deretic,et al.  A tale of two lipids: Mycobacterium tuberculosis phagosome maturation arrest. , 2004, Current opinion in microbiology.

[29]  V. Deretic,et al.  Mycobacterium tuberculosis Phagosome Maturation Arrest: Selective Targeting of PI3P‐Dependent Membrane Trafficking , 2003, Traffic.

[30]  Shengchang Su,et al.  Gallium Disrupts Iron Uptake by Intracellular and Extracellular Francisella Strains and Exhibits Therapeutic Efficacy in a Murine Pulmonary Infection Model , 2009, Antimicrobial Agents and Chemotherapy.

[31]  N. Hibler,et al.  Arrest of Mycobacterial Phagosome Maturation Is Caused by a Block in Vesicle Fusion between Stages Controlled by rab5 and rab7* , 1997, The Journal of Biological Chemistry.

[32]  P. Brennan,et al.  Synthesis of 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate and kinetic studies of Mycobacterium tuberculosis IspF. , 2010, Chemistry & biology.

[33]  Prabagaran Narayanasamy.  MEP Pathway: A Novel Pathway for New Antibiotics , 2015 .

[34]  H. Gendelman,et al.  Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  Vivek K. Bajpai,et al.  Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38 , 2017, Scientific Reports.

[36]  David G. Russell,et al.  Mycobacterium tuberculosis: here today, and here tomorrow , 2001, Nature Reviews Molecular Cell Biology.

[37]  J. Stokes,et al.  Gallium-Inducible Transferrin-Independent Iron Acquisition Is a Property of Many Cell Types: Possible Role of Alterations in the Plasma Membrane , 2005, Journal of Investigative Medicine.

[38]  Etienne Gagnon,et al.  The Phagosome Proteome: Insight into Phagosome Functions , 2001 .

[39]  I. H. Bechtold,et al.  An Isoniazid Analogue Promotes Mycobacterium tuberculosis-Nanoparticle Interactions and Enhances Bacterial Killing by Macrophages , 2012, Antimicrobial Agents and Chemotherapy.

[40]  D. Hsu,et al.  Critical role of galectin-3 in phagocytosis by macrophages. , 2003, The Journal of clinical investigation.

[41]  Pradeep K. Singh,et al.  The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. , 2007, The Journal of clinical investigation.

[42]  Amandeep Singh,et al.  Poly(lactide-co-glycolide)-rifampicin nanoparticles efficiently clear Mycobacterium bovis BCG infection in macrophages and remain membrane-bound in phago-lysosomes , 2013, Journal of Cell Science.

[43]  C. Ratledge.  Iron, mycobacteria and tuberculosis. , 2004, Tuberculosis.

[44]  J. Armstrong,et al.  Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival , 1975, The Journal of experimental medicine.